Eye scans to detect Alzheimer's-related proteins
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This study uses a special eye scan to look for abnormal protein deposits in the retina, which may be linked to Alzheimer's disease. It is for people who are generally healthy but have mild memory concerns or mild cognitive impairment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be generally healthy with mild memory complaints or mild cognitive impairment.
- Have a MoCA score between 22 and 28 (a cognitive screening test).
- Be willing to share results from an APOE gene test (a blood test for Alzheimer's risk).
- Not have an existing diagnosis of Alzheimer's or other dementia.
- Not be allergic to eye dilation drops.
- Not have severe glaucoma, severe cataracts, or other eye problems that prevent a clear scan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This extension study looks for predictors—measurable clues—linked to memory changes in older adults who feel their memory is worsening. You may be asked to have an amyloid PET scan, which can help researchers understand what might be driving memory concerns.
This study uses detailed eye imaging (an eye scan) to look for signs related to probable Alzheimer’s disease and mild dementia. It may help researchers understand whether eye scans can reflect brain changes and improve detection.
This study uses special eye scans and blood tests to find early signs of Alzheimer's disease. It aims to detect the disease before memory loss becomes severe, so treatment can start sooner.
This study uses detailed eye scans to look for changes that might relate to memory problems. You may be able to join if you are being seen for memory concerns and meet the health and eye-scan requirements.
This study uses a special camera (OCT) to take pictures of the retina (the back of your eye) to see if it can detect Alzheimer's disease very early. You may be eligible if you are either cognitively normal or have mild cognitive impairment, and have already had a test for Alzheimer's-related brain changes.
This study uses detailed eye imaging to look for patterns that may go along with conditions like Alzheimer’s disease, memory problems, multiple sclerosis, or eye/vascular issues. It may help researchers better understand how eye findings relate to health and disease.
Hear when a new Cognitive Dysfunction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.